West Pharma (WST) Tops Q4 EPS by 1c, Slight Miss on Revenues
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
West Pharma (WST) Declares $0.14 Quarterly Dividend, 0.6% Yield; Announces Up to 800K Share Buyback Program
February 15, 2018 6:16 AM ESTWest Pharma (NYSE: WST) declared a quarterly dividend of $0.14 per share, or $0.56 annualized.
The dividend will be payable on May 2, 2018, to stockholders of record on April 18, 2018, with an ex-dividend date of April 17, 2018.
The annual yield on the dividend is 0.6 percent.
Share... More
